Some researchers have reported that the expression of CXCL1 and CXCL2 is correlated with tumor size, metastasis, and decreased overall survival in breast, gastric, colorectal, hepatocellular, and bladder carcinoma patients26–30. This evidence concerns the gene CXCL1 and urinary bladder carcinoma.